Related references
Note: Only part of the references are listed.Large tumor suppressor kinase 2 overexpression attenuates 5-FU-resistance in colorectal cancer via activating the JNK-MIEF1-mitochondrial division pathway
Weilong Yao et al.
CANCER CELL INTERNATIONAL (2019)
Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells
Y. Shen et al.
PHARMACOGENOMICS JOURNAL (2018)
Rectal Cancer, Version 2.2018 Clinical Practice Guidelines in Oncology
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer
Katarzyna Morawska et al.
Oncotarget (2018)
Participation of CCL1 in Snail-Positive Fibroblasts in Colorectal Cancer Contribute to 5-Fluorouracil/Paclitaxel Chemoresistance
Ziqian Li et al.
CANCER RESEARCH AND TREATMENT (2018)
Emerging Systemic Therapies for Colorectal Cancer
Christine M. Veenstra et al.
CLINICS IN COLON AND RECTAL SURGERY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10
Tao Xie et al.
ONCOTARGET (2017)
miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin
Jia Han et al.
EXPERIMENTAL CELL RESEARCH (2017)
CQ synergistically sensitizes human colorectal cancer cells to SN-38/CPT-11 through lysosomal and mitochondrial apoptotic pathway via p53-ROS cross-talk
Pinjia Chen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
The extracellular domain of E cadherin linked to invasiveness in colorectal cancer: a new resistance and relapses monitoring serum-bio marker?
Niki Christou et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
MicroRNA-330 inhibited cell proliferation and enhanced chemosensitivity to 5-fluorouracil in colorectal cancer by directly targeting thymidylate synthase
Weidong Xu et al.
ONCOLOGY LETTERS (2017)
The role of GLI1 for 5-Fu resistance in colorectal cancer
Lining Zhang et al.
CELL AND BIOSCIENCE (2017)
HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins
Lei Sun et al.
JOURNAL OF CANCER (2017)
Identification of Predictive DNA Methylation Biomarkers for Chemotherapy Response in Colorectal Cancer
Rashidah Baharudin et al.
FRONTIERS IN PHARMACOLOGY (2017)
CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer
Xinfeng Yu et al.
SCIENTIFIC REPORTS (2017)
RAC3 influences the chemoresistance of colon cancer cells through autophagy and apoptosis inhibition
Maria Fernanda Rubio et al.
CANCER CELL INTERNATIONAL (2017)
Oncogenic role of PDK4 in human colon cancer cells
D. Leclerc et al.
BRITISH JOURNAL OF CANCER (2017)
MicroRNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of Programmed Cell Death 10
Ye Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade
Binhao Zhang et al.
ONCOLOGY REPORTS (2016)
Macrophages induce resistance to 5-fluorouracil chemotherapy in colorectal cancer through the release of putrescine
Xuan Zhang et al.
CANCER LETTERS (2016)
Cytoplasmic localization of Nrf2 promotes colorectal cancer with more aggressive tumors via upregulation of PSMD4
Po-Lin Lin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Role of TET enzymes in DNA methylation, development, and cancer
Kasper Dindler Rasmussen et al.
GENES & DEVELOPMENT (2016)
Suppression of TWIST1 enhances the sensitivity of colon cancer cells to 5-fluorouracil
Monika Sakowicz-Burkiewicz et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
High Infiltration of Tumor-Associated Macrophages Influences Poor Prognosis in Human Gastric Cancer Patients, Associates With the Phenomenon of EMT
Jia Zhang et al.
MEDICINE (2016)
Gap junction composed of connexin43 modulates 5-fluorouracil, oxaliplatin and irinotecan resistance on colorectal cancers
Zhao-Wei Zou et al.
MOLECULAR MEDICINE REPORTS (2016)
Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells
Lin Lv et al.
TUMOR BIOLOGY (2016)
Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
Samuel Goncalves-Ribeiro et al.
ONCOTARGET (2016)
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells
Gabriele Romano et al.
ONCOTARGET (2016)
MicroRNA-204 modulates colorectal cancer cell sensitivity in response to 5-fluorouracil-based treatment by targeting high mobility group protein A2
Haijun Wu et al.
BIOLOGY OPEN (2016)
miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2
Qingguo Li et al.
SCIENTIFIC REPORTS (2016)
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
K. Abiko et al.
BRITISH JOURNAL OF CANCER (2015)
MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells
Honghe Zhang et al.
CANCER LETTERS (2015)
Elevated microRNA-23a Expression Enhances the Chemoresistance of Colorectal Cancer Cells with Microsatellite Instability to 5-Fluorouracil by Directly Targeting ABCF1
Xiang Li et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2015)
PHD1 regulates p53-mediated colorectal cancer chemoresistance
Sofie Deschoemaeker et al.
EMBO MOLECULAR MEDICINE (2015)
Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer
Kenneth K. W. To et al.
EXPERIMENTAL CELL RESEARCH (2015)
MicroRNA-494 Sensitizes Colon Cancer Cells to Fluorouracil Through Regulation of DPYD
Jie Chai et al.
IUBMB LIFE (2015)
The role of interleukin-8 (CXCL8) and CXCR2 in acquired chemoresistance of human colorectal carcinoma cells HCT116
Daiva Dabkeviciene et al.
MEDICAL ONCOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sensitivity of apoptosis-resistant colon cancer cells to tanshinones is mediated by autophagic cell death and p53-independent cytotoxicity
Tao Hu et al.
PHYTOMEDICINE (2015)
MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer
Y. Zhang et al.
CELL DEATH & DISEASE (2015)
Promoter demethylation of nuclear factor-erythroid 2-related factor 2 gene in drug-resistant colon cancer cells
Xiao-Qian Zhao et al.
ONCOLOGY LETTERS (2015)
Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages
Ling Ding et al.
ONCOTARGET (2015)
Conditioned media from human macrophages of M1 phenotype attenuate the cytotoxic effect of 5-fluorouracil on the HT-29 colon cancer cell line
Alexander Hedbrant et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil
Xiangyong Li et al.
MOLECULAR MEDICINE REPORTS (2015)
Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro
Jun Deng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Overexpression of MicroRNA-122 Re-sensitizes 5-FU-Resistant Colon Cancer Cells to 5-FU Through the Inhibition of PKM2 In Vitro and In Vivo
Jinxia He et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2014)
Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis
Yasmine Touil et al.
CLINICAL CANCER RESEARCH (2014)
MicroRNA-23a Antisense Enhances 5-Fluorouracil Chemosensitivity Through APAF-1/Caspase-9 Apoptotic Pathway in Colorectal Cancer Cells
Jingli Shang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
microRNAs miR-27a and miR-27b Directly Regulate Liver Dihydropyrimidine Dehydrogenase Expression through Two Conserved Binding Sites
Steven M. Offer et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer
R. C. Turkington et al.
CELL DEATH & DISEASE (2014)
The β6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer
Song Liu et al.
CANCER LETTERS (2013)
FGFR4 Promotes Stroma-Induced Epithelial-to-Mesenchymal Transition in Colorectal Cancer
Rui Liu et al.
CANCER RESEARCH (2013)
TGF-β An emerging player in drug resistance
Diede Brunen et al.
CELL CYCLE (2013)
Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A
Fiorenza Lotti et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Coordinate Transcriptional and Translational Repression of p53 by TGF-β1 Impairs the Stress Response
Fernando J. Lopez-Diaz et al.
MOLECULAR CELL (2013)
Cell fusion promotes chemoresistance in metastatic colon carcinoma
V. Carloni et al.
ONCOGENE (2013)
Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancer
M. Griffith et al.
PHARMACOGENOMICS JOURNAL (2013)
The tumor microenvironment: a pitch for multiple players
Giovanna Schiavoni et al.
FRONTIERS IN ONCOLOGY (2013)
MicroRNA-10b is a Prognostic Indicator in Colorectal Cancer and Confers Resistance to the Chemotherapeutic Agent 5-Fluorouracil in Colorectal Cancer Cells
Naohiro Nishida et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
The emerging multiple roles of nuclear Akt
Alberto M. Martelli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Anti-tumor immunity: Myeloid leukocytes control the immune landscape
Melanie R. Rutkowski et al.
CELLULAR IMMUNOLOGY (2012)
P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance
M. A. de la Cruz-Morcillo et al.
ONCOGENE (2012)
Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells
Xin Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines
Huijuan Chai et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2011)
AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
Sarat Chandarlapaty et al.
CANCER CELL (2011)
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
Francesco Crea et al.
DRUG RESISTANCE UPDATES (2011)
The Inflammatory Microenvironment in Colorectal Neoplasia
Mairi H. McLean et al.
PLOS ONE (2011)
miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation
Valentina Boni et al.
MOLECULAR CANCER THERAPEUTICS (2010)
MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells
Pedro M. Borralho et al.
FEBS JOURNAL (2009)
Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells
William Fazzone et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance
Rita Humeniuk et al.
MOLECULAR CANCER THERAPEUTICS (2009)
p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest
Christian J. Braun et al.
CANCER RESEARCH (2008)
5-fluorouracil: Mechanisms of resistance and reversal strategies
Ning Zhang et al.
MOLECULES (2008)
SIRT1 is significantly elevated in mouse and human prostate cancer
Derek M. Huffman et al.
CANCER RESEARCH (2007)
Suppression of DPYD expression in RKO Cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression
Xue Zhang et al.
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE (2007)
The role of Sp1 and Sp3 in the constitutive DPYD gene expression
Xue Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2006)
Integrin-mediated drug resistance
Andreja Ambriovic-Ristov et al.
CURRENT SIGNAL TRANSDUCTION THERAPY (2006)
The power of the pump: Mechanisms of action of P-glycoprotein (ABCB1)
SV Ambudkar et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites
S Pratt et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance
YK Shin et al.
CANCER RESEARCH (2005)
DNA mismatch repair-dependent response to fluoropyrimidine-generated damage
M Meyers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Molecular mechanisms of drug resistance
DB Longley et al.
JOURNAL OF PATHOLOGY (2005)
Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan
J Boyer et al.
CLINICAL CANCER RESEARCH (2004)
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients
TL Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer:: Implication of TS expression in 5-FU-based adjuvant chemotherapy
S Kamoshida et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2004)
STRAP is a strong predictive marker of adjuvant chemotherapy benefit in colorectal cancer
M Buess et al.
NEOPLASIA (2004)
Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines
CN Arnold et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease
AJ Grant et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer
TK Bera et al.
MOLECULAR MEDICINE (2001)
Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44
R Singh et al.
GLYCOBIOLOGY (2001)
Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-xL in osteosarcoma cells
R Dey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
